Cefuroxime-Associated Pancreatitis

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61383082%3A_____%2F22%3A00001196" target="_blank" >RIV/61383082:_____/22:00001196 - isvavai.cz</a>
Alternative codes found
RIV/60162694:G44__/23:00557917
Result on the web
<a href="https://pubmed.ncbi.nlm.nih.gov/32769390/" target="_blank" >https://pubmed.ncbi.nlm.nih.gov/32769390/</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1097/MJT.0000000000001210" target="_blank" >10.1097/MJT.0000000000001210</a>

Result language
angličtina
Original language name
Cefuroxime-Associated Pancreatitis
Original language description
Drug-induced acute pancreatitis comprises only 0.1-2 % of all cases of acute pancreatitis. Because of a lack of evidence they are mostly given in the bigger group of idiopathic pancreatitis. A 79-year-old patient developed acute abdominal pain on the 4th day of taking cefuroxime. We establish the diagnosis of acute pancreatitis at admission by laboratory tests and a CT scan. Since the common causes of acute pancreatitis were during the hospitalisation excluded, we believe that the pancreatitis could be drug-induced. We would like to present to the best of our knowledge a first case of a possible cefuroxime induced acute pancreatitis.
Czech name
—
Czech description
—

Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30104 - Pharmacology and pharmacy

Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year
2022
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)